Clincosm LogoSign in Get a demo

MEA-WCVD: Middle East African Registry Women CardioVascular Disease

Sponsor
Tunisian Society of Cardiology and Cardiovascular Surgery (Other)
Overall Status
Recruiting
CT.gov ID
NCT05869214
Collaborator
(none)
2,000
Enrollment
1
Location
2
Anticipated Duration (Months)
998
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The MEA cardiology societies have joined forces to tackle the issue by establishing a tangible real-world data registry in every MEA country. This endeavor has resulted in the development of a multicenter registry called MEA-WCVD, which is being sponsored by each national cardiology society from participating countries. All data gathered will be consolidated into a singular registry for thorough analysis. Country specific analysis will be performed.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    2000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Middle East African Registry Women CardioVascular Disease
    Actual Study Start Date :
    May 10, 2023
    Anticipated Primary Completion Date :
    Jul 10, 2023
    Anticipated Study Completion Date :
    Jul 10, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Cardiovascular diseases care management in women will be compared to men in MEA countries according to current practice guidelines [2 months]

    Secondary Outcome Measures

    1. Identify inequalities between both genders in terms of: • Healthcare insurance • Incomes • Access to healthcare [2 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • All incomers in Cardiovascular (CV) diseases in hospital or out hospital facilities with one of the 4 diagnosis (Heart Failure (HF), Atrial fibrillation (AF), Valvular Heart disease (VHD), ischemic heart disease (IHD)

    • Age over 18 years old

    • Men and Women

    • Signature of consent form

    Exclusion Criteria:

    Patients with diseases other than the 4 previously mentioned in inclusion criteria

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hedi chaker Hospital Sfax Tunisia

    Sponsors and Collaborators

    • Tunisian Society of Cardiology and Cardiovascular Surgery

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Tunisian Society of Cardiology and Cardiovascular Surgery
    ClinicalTrials.gov Identifier:
    NCT05869214
    Other Study ID Numbers:
    • WCVD012023
    First Posted:
    May 22, 2023
    Last Update Posted:
    May 22, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Atrial Fibrillation
    Cardiovascular Diseases
    Heart Diseases
    Myocardial Ischemia
    Coronary Artery Disease
    Heart Valve Diseases

    Study Results

    No Results Posted as of May 22, 2023